Semaglutide 2.4 Mg for the Management of Overweight and Obesity: Systematic Literature Review and Meta-Analysis

por Smith, Inger, Hardy, Emily, Mitchell, Stephen, Batson, Sarah
Publicado 2022

Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom

por Sandhu, Hera, Xu, Weiwei, Olivieri, Anamaria-Vera, Lübker, Christopher, Smith, Inger, Antavalis, Vasileios
Publicado 2023

De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation

por Gal, Peter, Feldmajer, Gyorgyi, Augusto, Margarida, Gani, Ray, Hook, Emma, Bullement, Ash, Philips, Zoe, Smith, Inger
Publicado 2023